Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03011814
Title Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors City of Hope Medical Center
Indications

peripheral T-cell lymphoma

cutaneous T cell lymphoma

Sezary's disease

mycosis fungoides

Therapies

Durvalumab

Durvalumab + Lenalidomide

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.